SB

Saurav Bhala

Active Director Cfo DIN 10490964
DIN 10490964 First appointment Oct 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 4 historical roles
Total affiliations 5 Since Oct 2007
Shareholding value •••• Premium profile

About Saurav Bhala

Data last updated:

Saurav Bhala is a Cfo at Alivira Animal Health Limited (since 2023). The companies operate in Pharma and Chemicals. Alivira Animal Health Limited reported revenue of ₹393 Cr (FY 2025). Earlier, Saurav Bhala was a Cfo at Sequent Scientific Limited (2023–2026) and Manager at Bristol-Myers Squibb India Private Limited (2007–2008) and 2 more.

DIN 10490964
Primary Designation Cfo
Industry Pharma
First Appointment 11 Oct 2007
Oldest Company Age 19 yrs
Largest company Alivira Animal Health Limited · ₹393 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alivira Animal Health Limited U74120MH2013PLC248708
Cfo06 Nov 20232013₹393 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sequent Scientific Limited L99999TS1985PLC196357
Cfo06 Nov 20231985₹3,464 Cr (FY 2026)Active
Manager11 Oct 20072004₹882 Cr (FY 2025)Active
Astec Lifesciences Limited L99999MH1994PLC076236
Cfo25 Oct 20171994₹387 Cr (FY 2025)Active
Sequent Research Limited U24232TS2007PLC196886
Director13 Feb 20242007₹9.52 Cr (FY 2025)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Saurav Bhala

NameDINCompanyDesignation
Kamal Kishore Sharma00209430Alivira Animal Health LimitedDirector
Nihar Ranjan DasAlivira Animal Health LimitedCompany Secretary
Rajaram Narayanan02977405Alivira Animal Health LimitedManaging Director
Srinivas Vasireddy09771153Alivira Animal Health LimitedAdditional Director
Vijayalakshmi09228935Alivira Animal Health LimitedDirector

Directorship timeline

Open interactive timeline →
Sequent Research Limited
Alivira Animal Health Limited
Sequent Scientific Limited
Bristol-Myers Squibb India Private Limited
Premium access

Shareholding and investment profile for Saurav Bhala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saurav Bhala

Saurav Bhala currently holds 1 directorship: Alivira Animal Health Limited (Cfo, since 06 Nov 2023, revenue ₹393 Cr (FY 2025)).

Saurav Bhala was first appointed on 11 Oct 2007 as Manager at Bristol-Myers Squibb India Private Limited. The most recent appointment on record is 13 Feb 2024 at Sequent Research Limited.

Saurav Bhala held 4 earlier board appointments: Sequent Scientific Limited (Cfo, 06 Nov 2023 to 01 Jan 2026); Bristol-Myers Squibb India Private Limited (Manager, 11 Oct 2007 to 27 Feb 2008); Astec Lifesciences Limited (Cfo, 25 Oct 2017 to 30 Sep 2022); Sequent Research Limited (Director, from 13 Feb 2024).

The current boards of Saurav Bhala's companies include Kamal Kishore Sharma (Alivira Animal Health Limited), Nihar Ranjan Das (Alivira Animal Health Limited), Rajaram Narayanan (Alivira Animal Health Limited), Srinivas Vasireddy (Alivira Animal Health Limited), Vijayalakshmi (Alivira Animal Health Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available